Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.
Nuvectis Pharma has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Nuvectis Pharma is headquartered in Fort Lee, United States.
Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.
Nuvectis Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nuvectis Pharma — Funding & Investors." VCBacked, June 29, 2026, https://www.vcbacked.co/company/nuvectis-pharma. Accessed August 14, 2026.
VCBacked. (2026). Nuvectis Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nuvectis-pharma
{{cite web |title=Nuvectis Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nuvectis-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated